aethlonmedical.com - AEMD Company Value to Revenue Ratio

Public company logo of Aethlon Medical, Inc. (AEMD)

Aethlon Medical (AEMD) is protected by high regulatory barriers in the blood filtration niche thanks to its unique Hemopurifier. The technology physically removes pathogens and exosomes, complementing pharmacological cancer treatment. Growth is driven by government grants and successful clinical trials. The Enterprise Value to Sales ratio demonstrates the market reaction to news, where 0.00 forms the current metric value.

AEMD Aethlon Medical: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

AEMD (Aethlon): analytical breakdowns and indicator data

Fundamental valuation:Aethlon Medical AEMD
Mass-produced product of Aethlon Medical Inc

To stress-test positions, a pragmatic investor utilizes a metric that combines market capitalization and net debt divided by sales volume. The current 0.00 value regarding EV to revenue allows for a valuation of Aethlon Medical (AEMD) independent of macroeconomics, focusing attention on FDA regulatory risks and the progress of blood filter clinical trials when searching for consolidation zones.

Competitor analysis for Aethlon Medical

Enterprise Value-to-Revenue Multiple DexCom, Inc.|PEN: EV/Sales Multiple|Company Value to Revenue Ratio NOVT|HAE (Haemonetics Company) - EV/Sales Multiple|Inspire Sleep (INSP) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple PRCT|Company Value to Revenue CONMED Corporation CNMD|EV/Sales Multiple PLSE (pulsebiosciences.com)|EV/Sales Multiple InMode Ltd INMD|PMI: Company Value to Revenue|SRDX: Enterprise Value-to-Revenue Ratio|SENS (Senseonics Corp) - Company Value to Revenue|NeuroPace, Inc. - Business Value to Revenue|TCMD (Tactile Systems Technology, Inc.) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SANUWAVE Health SNWV|EV/Sales Multiple OM|Electromed Inc (ELMD) - Enterprise Value-to-Sales Ratio|LENSAR Inc - Company Value to Revenue|EV/Sales Multiple AVITA Medical, Inc. RCEL|Profound Medical Corp - EV/Sales Multiple|Total Company Value-to-Revenue Ratio Baird Medical BDMD|EDAP TMS (EDAP) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume APYX (Bovie Medical)|Enterprise Value-to-Revenue Ratio icecure-medical.com|Company Value to Revenue Pulmonx Corporation (LUNG)|EV/Sales Multiple TELA|CTSO - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Sensus Healthcare, Inc. SRTS|ZYXI: Company Value to Revenue Ratio|ECOR: Company Value to Revenue|Vicarious Surgical Inc - Enterprise Value-to-Revenue Coefficient|IINN: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple SeaStar Medical (ICU)|Enterprise Value-to-Revenue Ratio iridex.com|Company Value to Revenue Ratio INBS (Intelligent Bio Solutions Inc.)|Company Value to Revenue XAIR (Beyond Air, Inc.)|PFSA - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple SSKN (STRATA Skin Sciences Inc.)|GCTK - Company Value to Revenue|NAOV: Company Value to Revenue|Total Company Value-to-Revenue Ratio Venus Concept Inc. VERO|Nuwellis, Inc. (NUWE) - Enterprise Value-to-Revenue Ratio|TransEnterix (ASXC) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio Avinger|BSGM: Business Value to Revenue|EV/Sales Multiple CUTR|Total Company Value-to-Revenue Ratio Know Labs, Inc.|EV/Sales Multiple NARI (Inari Medical)|Business Value to Revenue NVRO|ReShape Lifesciences, Inc. - EV/Sales Multiple|Business Value to Revenue SILK (Silk Road Medical, Inc.)